|1|Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis. (25898974)
Bustany S.... Sola B.
|2|Cryptosporidiosis causing severe persistent diarrhea in a patient with multiple myeloma: A Case report and brief review of literature. (25006294)
Tandon N.... Gupta S.
|3|Treatment of multiple myeloma bone disease: experimental and clinical data. (25388648)
Papamerkouriou Y.M.... Kyrkos J.
|4|N-cadherin impedes proliferation of the multiple myeloma cancer stem cells. (24396705)
Sadler N.M.... Kirshner J.
|5|An old drug with a new future: bendamustine in multiple myeloma. (24053161)
Gentile M.... Morabito F.
|6|Cytogenetic classification in Korean multiple myeloma patients: Prognostic significance of hyperdiploidy with 47 to 50 chromosomes and the number of structural abnormalities. (24372944)
Lim J.H.... Kim S.R.
|7|How to determine bortezomib-based regimen for elderly patients with multiple myeloma: PAD versus CBd, an observational study. (24337419)
Huang B.T.... Chen R.L.
|8|Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth. (23446999)
Leone E.... Tassone P.
|9|Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma-to strengthen the case toward renal replacement therapy? (25356216)
Latus J.... Braun N.
|10|The effects of promoter methylation on downregulation of DAZAP2 in multiple myeloma cell lines. (22792345)
Luo S.Q.... Hu W.X.
|11|Effects of short-hairpin RNA-inhibited I^-catenin expression on the growth of human multiple myeloma cells in vitro and in vivo. (22609776)
Liang W.... Fu Q.
|12|Inhibition of JAK1/STAT3 signaling mediates compound K-induced apoptosis in human multiple myeloma U266 cells. (21420464)
Park S.... Kim S.H.
|13|BH3-only protein Bik is involved in both apoptosis induction and sensitivity to oxidative stress in multiple myeloma. (21063407)
Bodet L.... Gomez-Bougie P.
|14|Thrombotic thrombocytopenic purpura associated with disseminated varicella zoster in a multiple myeloma patient. (21260958)
Xu B.... Ritchie D.
|15|Interleukin-6 leads to interleukin-10 production in several human multiple myeloma cell lines. Does interleukin-10 enhance the proliferation of these cells? (19762082)
|16|Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death. (20920357)
Piazza F.... Semenzato G.
|17|Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells. (20011976)
Wang Q.... Zeng L.
|18|Tetraspanin-induced death of myeloma cell lines is autophagic and involves increased UPR signalling. (19755988)
Zismanov V.... Drucker L.
|19|MDR1 diplotypes as prognostic markers in multiple myeloma. (18408561)
Maggini V.... Rossi A.M.
|20|Tc-99m sestamibi uptake mimicking parathyroid adenoma in a patient with primary hyperparathyroidism and occult multiple myeloma. (18287846)
Chowdhury F.U.... Scarsbrook A.F.
|21|Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth. (17545613)
Tatetsu H.... Okuno Y.
|22|Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome. (17640854)
Mileshkin L.... Prince H.M.
|23|Heterogeneous expression of CD32 and CD32-mediated growth suppression in human myeloma cells. (16818279)
Zheng X.... Kawano M.M.
|24|Chemokines in multiple myeloma. (16982321)
Aggarwal R.... Roodman G.D.
|25|The association of increased p14ARF/p16INK4a and p15INK4a gene expression with proliferative activity and the clinical course of multiple myeloma. (17043023)
Sarasquete M.E.... San Miguel J.F.
|26|Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. (16396777)
Nakamura M.... Hata H.
|27|Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival. (15902294)
WuillA"me-Toumi S.... Bataille R.
|28|Successful transplantation of peripheral blood stem cells mobilized by chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma. (15531906)
Steidl U.... Kobbe G.
|29|CIDP and isolated osteosclerotic myeloma. (15623724)
Nickel J.... KAPller H.
|30|The structure, expression and function prediction of DAZAP2, a down-regulated gene in multiple myeloma. (15629043)
Shi Y.... Hu W.
|31|Advances in biology and therapy of multiple myeloma. (14633785)
BarillAc-Nion S.... Tricot G.
|32|Serum oncostatin M in multiple myeloma: impact on disease severity and prognosis. (10914939)
Koskela K.... Remes K.
|33|CD44 isoforms distinguish between bone marrow plasma cells from normal individuals and patients with multiple myeloma at different stages of disease. (9823960)
van Driel M.... Bloem A.C.
|34|Interleukin-2-mediated modulation of plasma cell tumor growth in a model of multiple myeloma. (9458238)
Kopantzev E.... Rudikoff S.
|35|Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes. (9558394)
PAcrez-SimA^n J.A.... OrfALo A.
|36|Modulation of interleukin-6/interleukin-6 receptor cytokine loop in the treatment of multiple myeloma. (9373192)
Chen Y.H.... Lavelle D.
|37|Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cells. (9815779)
Ogata A.... Anderson K.C.
|38|Myeloma cell growth arrest, apoptosis, and interleukin-6 receptor modulation induced by EB1089, a vitamin D3 derivative, alone or in association with dexamethasone. (8977259)
Puthier D.... Amiot M.
|39|Amyotrophic lateral sclerosis associated with multiple myeloma, endocrinopathy and skin changes suggestive of a POEMS syndrome variant. (7595623)
Gericke C.A.... Ludolph A.C.
|40|Interferon-gamma in multiple myeloma. (8535185)
Palumbo A.... Pileri A.
|41|Optimal blood stem cell mobilization using 10 micrograms/kg granulocyte colony-stimulating factor (G-CSF) alone for high-dose melphalan intensification in multiple myeloma: an intrapatient controlled study. (7522395)
Feremans W.... Capel P.
|42|Objective response of multiple myeloma to cyclosporin A. (7696923)
Wiernik P.H.... Rosenstreich D.L.
|43|Potential use of IgA protease therapy in IgA myeloma patients. (8502191)
|44|Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. (1391937)
Jagannath S.... Barlogie B.
|45|Myeloma phenotype: clues to disease origin and manifestation. (1582972)
|46|In vitro growth pattern of myeloma cells in liquid suspension or semi-solid culture containing interleukin-6. (1954351)
Okuno Y.... Imura H.
|47|Serum levels of interleukin-6 in multiple myeloma and other hematological disorders: correlation with disease activity and other prognostic parameters. (2031968)
Nachbaur D.M.... Huber H.
|48|Analysis of methylation in the c-MYC gene in five human myeloma cell lines. (2004018)
Ohtsuki T.... Namba M.
|49|Chronic neutrophilic leukemia and myeloma. Report on long survival. (6585081)
Franchi F.... Giunchi G.
|50|Panhypopituitarism due to multiple myeloma. (5415797)